Skip to content

Efficacy Evaluation of Yanglao Acupoint Combined with Twelve-Character Formula Movement Acupuncture for Axial Spondyloarthritis

Efficacy Evaluation of Yanglao Acupoint Combined with Twelve-Character Formula Movement Acupuncture for Axial Spondyloarthritis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001266
Enrollment
Unknown
Registered
2025-06-26
Start date
2025-07-13
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Axial Spondyloarthritis

Interventions

Treatment Group: Twelve-Character Formula Movement Acupuncture
Control Group:Adalimumab combined with traditional Chinese medicine (TCM) treatment

Sponsors

Longhua Hospital affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) Aged 18 to 60 years regardless of gender; (2) Meeting the classification criteria for axial spondyloarthritis (AxSpA) established by the International Spondyloarthritis Assessment Society (ASAS) in 2009; (3) With low back pain or stiffness symptoms and an ASDAS-CRP score =1.3; (4) Capable of making judgments about general conditions and able to cooperate in evaluating symptoms signs and other items; (5) Requiring stable-dose use of adalimumab for 3 months and oral traditional Chinese medicine (TCM) compound preparations at a stable dose for 2 weeks before enrollment; (6) Providing informed consent to participate and signing the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Patients with unilateral or bilateral joints meeting the AS radiological diagnostic criteria at grade IV; (2) Those who have participated in or are currently enrolled in other clinical trials within the past 3 months; (3) Individuals concurrently receiving other external treatments such as acupuncture or tuina (Chinese massage); (4) Patients with mental disorders or inability to cooperate; (5) Pregnant or lactating women, or those planning to conceive; (6) Individuals with severe cardiovascular, cerebrovascular, pulmonary, hepatic, renal, or other systemic diseases; (7) Those with metal allergies or severe needle phobia.

Design outcomes

Primary

MeasureTime frame
Ankylosing Spondylitis Disease Activity Score based on C-reactive protein(ASDAS-CRP);

Secondary

MeasureTime frame
C-reactive protein (CRP);Bath Ankylosing Spondylitis Metrology Index(BASMI);Erythrocyte Sedimentation Rate (ESR);ASAS Health Index(ASAS HI);Bath AS Disease Activity Index(BASDAI);Bath Ankylosing Spondylitis Functional Index(BASFI);

Countries

China

Contacts

Public ContactWang Xiao

Longhua Hospital affiliated to Shanghai University of Traditional Chinese Medicine

John2007lucky@163.com13472887260

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026